Translational Cancer Research

0.6(top 50%)

impact factor

3.5K(top 5%)

papers

11.4K(top 20%)

citations

33(top 20%)

h-index

0.7(top 50%)

impact factor

4.0K

all documents

13.3K

doc citations

60(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	DNA double strand break repair via non-homologous end-joining	Translational Cancer Research	2013	403
2	Cancer biomarker discovery and validation	Translational Cancer Research	2015	354
3	DNA damage tolerance: a double-edged sword guarding the genome	Translational Cancer Research	2013	153
4	Exosomal lncRNAs as new players in cell-to-cell communication	Translational Cancer Research	2018	150
5	The role of deep learning and radiomic feature extraction in cancer-specific predictive modelling: a review	Translational Cancer Research	2018	128
6	Prostate cancer radiomics and the promise of radiogenomics	Translational Cancer Research	2016	111
7	Radiomics in head and neck cancer: from exploration to application	Translational Cancer Research	2016	106
8	TP53 mutations in epithelial ovarian cancer	Translational Cancer Research	2016	91
9	MDM2 and MDMX: Alone and together in regulation of p53	Translational Cancer Research	2012	89
10	Normal tissue protection for improving radiotherapy: Where are the Gaps?	Translational Cancer Research	2012	88
11	Impact of image preprocessing on the volume dependence and prognostic potential of radiomics features in non-small cell lung cancer	Translational Cancer Research	2016	87
12	Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment	Translational Cancer Research	2012	82
13	Renal cell carcinoma: the search for a reliable biomarker	Translational Cancer Research	2017	78
14	Tumor microenvironment and nanotherapeutics	Translational Cancer Research	2013	77
15	SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis	Translational Cancer Research	2012	73
16	Radiomics applied to lung cancer: a review	Translational Cancer Research	2016	71
17	Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury	Translational Cancer Research	2013	69
18	DNA crosslinking damage and cancer - a tale of friend and foe	Translational Cancer Research	2013	65
19	Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization	Translational Cancer Research	2013	64
20	Functions of polyphenols and its anticancer properties in biomedical research: a narrative review	Translational Cancer Research	2020	63
21	Circular RNAs and competing endogenous RNA (ceRNA) networks	Translational Cancer Research	2018	63
22	Radiomics in glioblastoma: current status, challenges and potential opportunities	Translational Cancer Research	2016	57
23	Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications	Translational Cancer Research	2015	57
24	Computational resources for radiomics	Translational Cancer Research	2016	56
25	Intestinal stem cell injury and protection during cancer therapy	Translational Cancer Research	2013	54
26	Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosis	Translational Cancer Research	2013	51
27	In vivo cancer metabolism is defined by the nutrient microenvironment	Translational Cancer Research	2016	50
28	EGFR first- and second-generation TKIs—there is still place for them in EGFR-mutant NSCLC patients	Translational Cancer Research	2018	48
29	Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis	Translational Cancer Research	2016	44
30	Targeting ROS1 rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors	Translational Cancer Research	2018	43
31	Translational research in radiation-induced DNA damage signaling and repair	Translational Cancer Research	2017	40
32	Third generation gold nanoplatform optimized for radiation therapy	Translational Cancer Research	2013	39
33	Regulation of cytotoxic T-cell responses by p53 in cancer	Translational Cancer Research	2016	37
34	Radiomics for rectal cancer	Translational Cancer Research	2016	34
35	Defining functional changes in the brain caused by targeted stereotaxic radiosurgery	Translational Cancer Research	2014	34
36	The promise and challenge of ovarian cancer models	Translational Cancer Research	2015	34
37	Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire	Translational Cancer Research	2015	34
38	IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm	Translational Cancer Research	2017	33
39	Sarcopenia in aging, obesity, and cancer	Translational Cancer Research	2020	33
40	MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers	Translational Cancer Research	2020	33
41	The emerging role of chemokine receptor CXCR2 in cancer progression	Translational Cancer Research	2016	33
42	Exosomes as critical mediators of cell-to-cell communication in cancer pathogenesis and their potential clinical application	Translational Cancer Research	2019	32
43	Integrative clustering methods for high-dimensional molecular data	Translational Cancer Research	2014	32
44	The emerging field of radiomics in esophageal cancer: current evidence and future potential	Translational Cancer Research	2016	31
45	ONC201: a new treatment option being tested clinically for recurrent glioblastoma	Translational Cancer Research	2017	31
46	Helios—controller of Treg stability and function	Translational Cancer Research	2016	30
47	Indoor radon exposure and lung cancer risk: a meta-analysis of case-control studies	Translational Cancer Research	2017	28
48	Cancer stem cells in glioma: challenges and opportunities	Translational Cancer Research	2013	28
49	DNA ligases as therapeutic targets	Translational Cancer Research	2013	28
50	Applications of hyperspectral imaging in the detection and diagnosis of solid tumors	Translational Cancer Research	2020	27

Scientometrics

Overviews

Citing Bodies

Translational Cancer Research

Top Articles